Literature DB >> 33232302

Phenotypes of CF rabbits generated by CRISPR/Cas9-mediated disruption of the CFTR gene.

Jie Xu1, Alessandra Livraghi-Butrico2, Xia Hou3, Carthic Rajagopalan3, Jifeng Zhang1, Jun Song1, Hong Jiang3, Hong-Guang Wei3, Hui Wang4, Mohamad Bouhamdan3, Jinxue Ruan1, Dongshan Yang1, Yining Qiu5, Youming Xie4, Ronald Barrett6, Sharon McClellan6, Hongmei Mou7, Qingtian Wu3, Xuequn Chen3, Troy D Rogers2, Kristen J Wilkinson2, Rodney C Gilmore2, Charles R Esther2, Khalequz Zaman8, Xiubin Liang1, Michael Sobolic3, Linda Hazlett6, Kezhong Zhang5, Raymond A Frizzell9, Martina Gentzsch2, Wanda K O'Neal2, Barbara R Grubb2, Y Eugene Chen1, Richard C Boucher2, Fei Sun3.   

Abstract

Existing animal models of cystic fibrosis (CF) have provided key insights into CF pathogenesis but have been limited by short lifespans, absence of key phenotypes, and/or high maintenance costs. Here, we report the CRISPR/Cas9-mediated generation of CF rabbits, a model with a relatively long lifespan and affordable maintenance and care costs. CF rabbits supplemented solely with oral osmotic laxative had a median survival of approximately 40 days and died of gastrointestinal disease, but therapeutic regimens directed toward restoring gastrointestinal transit extended median survival to approximately 80 days. Surrogate markers of exocrine pancreas disorders were found in CF rabbits with declining health. CFTR expression patterns in WT rabbit airways mimicked humans, with widespread distribution in nasal respiratory and olfactory epithelia, as well as proximal and distal lower airways. CF rabbits exhibited human CF-like abnormalities in the bioelectric properties of the nasal and tracheal epithelia. No spontaneous respiratory disease was detected in young CF rabbits. However, abnormal phenotypes were observed in surviving 1-year-old CF rabbits as compared with WT littermates, and these were especially evident in the nasal respiratory and olfactory epithelium. The CF rabbit model may serve as a useful tool for understanding gut and lung CF pathogenesis and for the practical development of CF therapeutics.

Entities:  

Keywords:  Cell Biology; Genetic diseases; Ion channels; Pulmonology

Mesh:

Substances:

Year:  2021        PMID: 33232302      PMCID: PMC7821608          DOI: 10.1172/jci.insight.139813

Source DB:  PubMed          Journal:  JCI Insight        ISSN: 2379-3708


  81 in total

1.  The mucus bundles responsible for airway cleaning are retained in cystic fibrosis and by cholinergic stimulation.

Authors:  Anna Ermund; Lauren N Meiss; Brendan Dolan; Andrea Bähr; Nikolai Klymiuk; Gunnar C Hansson
Journal:  Eur Respir J       Date:  2018-08-30       Impact factor: 16.671

2.  Loss of cystic fibrosis transmembrane conductance regulator function produces abnormalities in tracheal development in neonatal pigs and young children.

Authors:  David K Meyerholz; David A Stoltz; Eman Namati; Shyam Ramachandran; Alejandro A Pezzulo; Amanda R Smith; Michael V Rector; Melissa J Suter; Simon Kao; Geoffrey McLennan; Guillermo J Tearney; Joseph Zabner; Paul B McCray; Michael J Welsh
Journal:  Am J Respir Crit Care Med       Date:  2010-07-09       Impact factor: 21.405

Review 3.  Dietary and developmental regulation of intestinal sugar transport.

Authors:  R P Ferraris
Journal:  Biochem J       Date:  2001-12-01       Impact factor: 3.857

4.  Mucus accumulation in the lungs precedes structural changes and infection in children with cystic fibrosis.

Authors:  Charles R Esther; Marianne S Muhlebach; Camille Ehre; David B Hill; Matthew C Wolfgang; Mehmet Kesimer; Kathryn A Ramsey; Matthew R Markovetz; Ian C Garbarine; M Gregory Forest; Ian Seim; Bryan Zorn; Cameron B Morrison; Martial F Delion; William R Thelin; Diane Villalon; Juan R Sabater; Lidija Turkovic; Sarath Ranganathan; Stephen M Stick; Richard C Boucher
Journal:  Sci Transl Med       Date:  2019-04-03       Impact factor: 17.956

5.  Early severe anemia as the first sign of cystic fibrosis.

Authors:  Tugba Sismanlar; Ayşe Tana Aslan; Mehmet Köse; Sevgi Pekcan; Fatih Süheyl Ezgü; Işıl İrem Budakoğlu; İdil Yenicesu
Journal:  Eur J Pediatr       Date:  2016-08-05       Impact factor: 3.183

Review 6.  Animal and model systems for studying cystic fibrosis.

Authors:  Bradley H Rosen; Marc Chanson; Lara R Gawenis; Jinghua Liu; Aderonke Sofoluwe; Alice Zoso; John F Engelhardt
Journal:  J Cyst Fibros       Date:  2017-09-19       Impact factor: 5.482

7.  Incidence of distal intestinal obstruction syndrome in cystic fibrosis.

Authors:  B J Rosenstein; T S Langbaum
Journal:  J Pediatr Gastroenterol Nutr       Date:  1983-05       Impact factor: 2.839

8.  Distribution of nonciliated bronchiolar epithelial (Clara) cells in intra- and extrapulmonary airways of the rabbit.

Authors:  C G Plopper; J E Halsebo; W J Berger; K S Sonstegard; P Nettesheim
Journal:  Exp Lung Res       Date:  1983-09       Impact factor: 2.459

9.  Ion transport across the jejunum in normal and cystic fibrosis mice.

Authors:  B R Grubb
Journal:  Am J Physiol       Date:  1995-03

10.  Mucus clearance, MyD88-dependent and MyD88-independent immunity modulate lung susceptibility to spontaneous bacterial infection and inflammation.

Authors:  A Livraghi-Butrico; E J Kelly; E R Klem; H Dang; M C Wolfgang; R C Boucher; S H Randell; W K O'Neal
Journal:  Mucosal Immunol       Date:  2012-03-14       Impact factor: 7.313

View more
  7 in total

Review 1.  Animal models of cystic fibrosis in the era of highly effective modulator therapies.

Authors:  Barbara R Grubb; Alessandra Livraghi-Butrico
Journal:  Curr Opin Pharmacol       Date:  2022-05-13       Impact factor: 4.768

Review 2.  On the Corner of Models and Cure: Gene Editing in Cystic Fibrosis.

Authors:  Marjolein Ensinck; Angélique Mottais; Claire Detry; Teresinha Leal; Marianne S Carlon
Journal:  Front Pharmacol       Date:  2021-04-27       Impact factor: 5.810

Review 3.  Gene Editing in Rabbits: Unique Opportunities for Translational Biomedical Research.

Authors:  Jie Xu; Jifeng Zhang; Dongshan Yang; Jun Song; Brooke Pallas; Chen Zhang; Jiafen Hu; Xuwen Peng; Neil D Christensen; Renzhi Han; Y Eugene Chen
Journal:  Front Genet       Date:  2021-01-28       Impact factor: 4.599

4.  Production of CFTR-ΔF508 Rabbits.

Authors:  Dongshan Yang; Xiubin Liang; Brooke Pallas; Mark Hoenerhoff; Zhuoying Ren; Renzhi Han; Jifeng Zhang; Y Eugene Chen; Jian-Ping Jin; Fei Sun; Jie Xu
Journal:  Front Genet       Date:  2021-01-22       Impact factor: 4.599

Review 5.  The Potential of CRISPR/Cas9 Gene Editing as a Treatment Strategy for Inherited Diseases.

Authors:  Sameh A Abdelnour; Long Xie; Abdallah A Hassanin; Erwei Zuo; Yangqing Lu
Journal:  Front Cell Dev Biol       Date:  2021-12-15

6.  The sodium/glucose cotransporters as potential therapeutic targets for CF lung diseases revealed by human lung organoid swelling assay.

Authors:  Hiroyuki Hirai; Xiubin Liang; Yifei Sun; Yihan Zhang; Jifeng Zhang; Y Eugene Chen; Hongmei Mou; Youyang Zhao; Jie Xu
Journal:  Mol Ther Methods Clin Dev       Date:  2021-11-24       Impact factor: 6.698

7.  Elastic mucus strands impair mucociliary clearance in cystic fibrosis pigs.

Authors:  Maria I Pino-Argumedo; Anthony J Fischer; Brieanna M Hilkin; Nicholas D Gansemer; Patrick D Allen; Eric A Hoffman; David A Stoltz; Michael J Welsh; Mahmoud H Abou Alaiwa
Journal:  Proc Natl Acad Sci U S A       Date:  2022-03-24       Impact factor: 12.779

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.